Rebecca Kruse-Jarres

Rebecca Kruse-Jarres

UNVERIFIED PROFILE

Are you Rebecca Kruse-Jarres?   Register this Author

Register author
Rebecca Kruse-Jarres

Rebecca Kruse-Jarres

Publications by authors named "Rebecca Kruse-Jarres"

Are you Rebecca Kruse-Jarres?   Register this Author

37Publications

795Reads

35Profile Views

Urinary cross-linked carboxyterminal telopeptide, a bone resorption marker, decreases after vaso-occlusive crises in adults with sickle cell disease.

Blood Cells Mol Dis 2020 02 24;80:102369. Epub 2019 Oct 24.

Department of Medicine, Division of Hematology, University of Washington School of Medicine, Seattle, WA, United States of America; Washington Center for Bleeding Disorders at Bloodworks Northwest, University of Washington, Seattle, WA, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2019.102369DOI Listing
February 2020

Emicizumab in Hemophilia A.

N Engl J Med 2020 02;382(8):785

University of Manchester, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1916299DOI Listing
February 2020

Emicizumab for hemophilia A without inhibitors.

Expert Rev Hematol 2019 07 4;12(7):515-524. Epub 2019 Jun 4.

a Department of Hematology and Medical Oncology , Emory University School of Medicine , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1624519DOI Listing
July 2019

Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting.

Haemophilia 2019 Mar 6;25(2):213-220. Epub 2019 Feb 6.

Haemophilia Comprehensive Care Centre, Faculty of Health Sciences, University of the Witwatersrand and NHLS, Parktown, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hae.13655DOI Listing
March 2019

Emicizumab for hemophilia A with factor VIII inhibitors.

Expert Rev Hematol 2018 11 10;11(11):835-846. Epub 2018 Oct 10.

f Department of Pediatrics , University of Michigan , Ann Arbor , MI , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2018.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2018.1531701DOI Listing
November 2018

Serum 25-Hydroxyvitamin D and Diet Mediates Vaso-Occlusive Related Hospitalizations in Sickle-Cell Disease Patients.

Nutrients 2018 Sep 29;10(10). Epub 2018 Sep 29.

Section of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6643/10/10/1384
Publisher Site
http://dx.doi.org/10.3390/nu10101384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212983PMC
September 2018

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.

N Engl J Med 2018 08;379(9):811-822

From the Haemophilia Comprehensive Care Centre, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg (J.M.); Universitätsklinikum Bonn, Bonn, Germany (J.O.); Genentech, South San Francisco, CA (I.P.-P., J.I.A., G.G.L.); Louis Pradel University Hospital, Lyon, France (C.N.); F. Hoffmann-La Roche, Basel, Switzerland (M.N., C.S., C.D., E.A.); Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan (M.E.M.); the Hematology Department, Hospital Universitario La Paz, Autónoma University, Madrid (V.J.-Y.); the Department of Hematology and Medical Oncology, Emory School of Medicine, Atlanta (C.K.); Children's Hospital of Michigan, Detroit (M.U.C.); Instituto Costarricense de Investigaciones Científicas, San José, Costa Rica (W.B.); the Department of Pediatrics, Nara Medical University, Kashihara, Japan (M.S.); and the Washington Center for Bleeding Disorders at Bloodworks Northwest, Seattle (R.K.-J.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1803550
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1803550DOI Listing
August 2018

How I treat type 2B von Willebrand disease.

Blood 2018 03 29;131(12):1292-1300. Epub 2018 Jan 29.

Washington Center for Bleeding Disorders at Bloodworks Northwest, Seattle, WA; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-06-742692DOI Listing
March 2018

Balance, falls, and exercise: Beliefs and experiences in people with hemophilia: A qualitative study.

Res Pract Thromb Haemost 2018 Jan 4;2(1):147-154. Epub 2017 Dec 4.

Washington Center for Bleeding Disorders Bloodworks Northwest Seattle WA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rth2.12060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055559PMC
January 2018

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

N Engl J Med 2017 08 10;377(9):809-818. Epub 2017 Jul 10.

From Universitätsklinikum Bonn, Bonn, Germany (J.O.); the Haemophilia Comprehensive Care Centre, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg (J.N.M.); Genentech, South San Francisco (B.K., N.V., G.G.L.), and Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles (G.Y.) - both in California; F. Hoffmann-La Roche, Basel, Switzerland (C.S., E.A.); Children's Hospital of Michigan, Detroit (M.U.C.); the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Foundation, Ospedale Maggiore Policlinico, Milan (E.S.); Bloodworks Northwest, Seattle (R.K.-J.); Louis Pradel Cardiology Hospital, University Claude Bernard, Lyon, France (C.N.); Georgetown University Medical Center, Washington, DC (C.K.); the Department of Disorders of Hemostasis and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland (J.W.); and the Department of Pediatrics, Nara Medical University, Kashihara, Japan (M.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1703068DOI Listing
August 2017

Acquired hemophilia A: Updated review of evidence and treatment guidance.

Am J Hematol 2017 Jul 5;92(7):695-705. Epub 2017 Jun 5.

Section of Hematology/Oncology, Georgetown University, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24777DOI Listing
July 2017

The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study.

Int J Hypertens 2016 14;2016:2014201. Epub 2016 Nov 14.

Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA, USA; Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/2014201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124662PMC
November 2016

Acquired bleeding disorders in the elderly.

Hematology Am Soc Hematol Educ Program 2015 ;2015:231-6

Washington Center for Bleeding Disorders at Bloodworks Northwest and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2015.1.231DOI Listing
October 2016

The evolving role and future relevance of plasma-derived therapies in the management of bleeding disorders.

Thromb Haemost 2016 08 16;116 Suppl 1:S1. Epub 2016 Aug 16.

Victor Jiménez-Yuste, Department of Haematology, Autónoma University Madrid and La Paz University Hospital, Pº de la Castellana, 261, 28046 Madrid, Spain, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH16-01-0047DOI Listing
August 2016

Women leaders in hematology: Inspirations & insights.

Am J Hematol 2016 Apr;91 Suppl 1:S6-S34

Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24316DOI Listing
April 2016

A new era for hemophilia B treatment.

Blood 2016 Apr;127(14):1734-6

BLOODWORKS NORTHWEST.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-02-694869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825410PMC
April 2016

How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors.

Blood 2015 Jul 31;126(2):153-9. Epub 2015 Mar 31.

Washington Center for Bleeding Disorders, Bloodworks Northwest, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-551952DOI Listing
July 2015

Acquired hemophilia A: emerging treatment options.

J Blood Med 2015 8;6:143-50. Epub 2015 May 8.

Washington Center for Bleeding Disorders, Blood Works NW, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/JBM.S77332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431493PMC
June 2015

Identification and basic management of bleeding disorders in adults.

J Am Board Fam Med 2014 Jul-Aug;27(4):549-64

From the Department of Medicine (RKJ, CAL), and the Department of Pediatrics (TCS), Tulane University School of Medicine, New Orleans, Louisiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3122/jabfm.2014.04.130227DOI Listing
April 2015

Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke.

Stroke 2014 Sep 15;45(9):2789-91. Epub 2014 Jul 15.

From the Stroke Program, Department of Neurology (A. Samai, D.M., A. Shaban, A.G., L.D., L.S., R.E.K., S.M.-S.) and Section of Hematology/Oncology, Department of Medicine (R.K.-J.) Tulane University School of Medicine, New Orleans, LA; and Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, New Orleans, LA (A. Samai).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.114.006394DOI Listing
September 2014

Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state.

Clin Appl Thromb Hemost 2014 Mar 14;20(2):124-8. Epub 2013 May 14.

1Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, LA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029613488936DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603284PMC
March 2014

Management of sickle cell disease from childhood through adulthood.

Blood Rev 2013 Nov 19;27(6):279-87. Epub 2013 Sep 19.

Department of Pediatric Hematology-Oncology, Sickle Cell Research, Medical University of South Carolina, Charleston, SC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2013.09.001DOI Listing
November 2013

Current controversies in the formation and treatment of alloantibodies to factor VIII in congenital hemophilia A.

Hematology Am Soc Hematol Educ Program 2011 ;2011:407-12

Tulane University School of Medicine, New Orleans, LA 70112, USA.

View Article

Download full-text PDF

Source
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2011.1.407DOI Listing
April 2012

Reduced production of IFN-γ and LT-α is associated with successful prednisone therapy in patients with acquired hemophilia A: a pilot study.

Thromb Res 2011 Nov 23;128(5):e86-90. Epub 2011 Jul 23.

Tulane University Health Sciences Center, Tulane School of Medicine, Section of Hematology/Oncology, Louisiana Comprehensive Hemophilia Care Center, New Orleans, LA 70112-2699, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S004938481100346
Publisher Site
http://dx.doi.org/10.1016/j.thromres.2011.06.032DOI Listing
November 2011

Emergency department care for patients with hemophilia and von Willebrand disease.

J Emerg Med 2010 Aug 30;39(2):158-65. Epub 2008 Aug 30.

Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2007.12.024DOI Listing
August 2010

Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A.

Expert Opin Biol Ther 2008 Dec;8(12):1885-96

Louisiana Center for Bleeding and Clotting Disorders - TB-31, 1430 Tulane Avenue, New Orleans, Louisiana 70221-2699, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712590802515537DOI Listing
December 2008

Current management of acquired factor VIII inhibitors.

Curr Opin Hematol 2008 Sep;15(5):451-5

Tulane University School of Medicine, New Orleans, Louisiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328309ecabDOI Listing
September 2008